CoChat

Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project

Open access
Corazza, Ornella, Assi, Sulaf, Simonato, Pierluigi, Corkery, John, Bersani, Francesco Saverio, Demetrovics, Zsolt, Stair, Jacqueline, Fergus, Suzanne, Pezzolesi, Cinzia, Pasinetti, Manuela, Deluca, Paolo, Drummond, Colin, Davey, Zoe, Blaszko, Ursula, Moskalewicz, Jacek, Mervo, Barbara, Furia, Lucia Di, Farre, Maggi, Flesland, Liv, Pisarska, Agnieszka, Shapiro, Harry, Siemann, Holger, Skutle, Arvid, Sferrazza, Elias, Torrens, Marta, Sambola, F., van der Kreeft, Peer, Scherbaum, Norbert, Schifano, Fabrizio · 2013 · Human Psychopharmacology: Clinical and Experimental
Cited by 168

The DOI matches its Crossref record.

Abstract

Objectives: The recent emergence of new psychoactive compounds (novel psychoactive substances (NPS)) has raised prominent challenges in the fields of drug policy, substance use research, public health and service provision. The Recreational Drugs European Network project, funded by the European Commission, was implemented to improve the information stream to young people and professionals about effects/risks of NPS by identifying online products and disseminating relevant information through technological tools. Methods: Regular multilingual qualitative assessments of websites, drugs fora and other online resources were carried out using the Google search engine in eight languages from collaborating countries. These included the following: the UK, Norway, Belgium, Germany, Hungary, Poland, Italy and Spain. Products were tested and prevention messages were developed and disseminated via technological tools such as interactive websites, SMS alert, social networking (Facebook, Twitter), Multimedia (You Tube), Smartphone applications (iPhone) and virtual learning environments (Second Life). Results: The Recreational Drugs European Network project established itself as the first Europe‐wide prevention programme designed for NPS based on the efficacy of novel information and communication technology‐based forms of intervention. More than 650 NPS products and combinations were identified; relevant information was disseminated to target population and advice was given to both European Union/international agencies and national policy makers. Conclusions: Web‐monitoring activities are essential for mapping the diffusion of NPS and the use of technological tools can be successfully incorporated in specific prevention programmes. Furthermore, the involvement of multi‐disciplinary international partnerships was and continues to be fundamental for responding to such a prominent challenge. Copyright © 2013 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.2299

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 168

Metadata

Authors
Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., Stair, J., Fergus, S., Pezzolesi, C., Pasinetti, M., Deluca, P., Drummond, C., Davey, Z., Blaszko, U., Moskalewicz, J., Mervo, B., Furia, L. D., Farre, M., Flesland, L., Pisarska, A., Shapiro, H., Siemann, H., Skutle, A., Sferrazza, E., Torrens, M., Sambola, F., van der Kreeft, P., Scherbaum, N., & Schifano, F.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2013-07
Volume
28
Issue
4
Pages
317-323
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W1593305029
Cited by
168
References
0
FWCI
21.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project. https://app.cochat.ai/papers/10.1002/hup.2299
The paper
Corazza, O., Assi, S., Simonato, P., Corkery, J., Bersani, F. S., Demetrovics, Z., Stair, J., Fergus, S., Pezzolesi, C., Pasinetti, M., Deluca, P., Drummond, C., Davey, Z., Blaszko, U., Moskalewicz, J., Mervo, B., Furia, L. D., Farre, M., Flesland, L., . . . Schifano, F. (2013). Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2299

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.